1 558 138 COST-EFFECTIVENESS OF YOGA FOR MANAGING MUSCULOSKELETAL CONDITIONS IN THE WORKPLACE. BACKGROUND: BACK PAIN AND MUSCULOSKELETAL CONDITIONS NEGATIVELY AFFECT THE HEALTH-RELATED QUALITY OF LIFE (HRQL) OF EMPLOYEES AND GENERATE SUBSTANTIAL COSTS TO EMPLOYERS. AIMS: TO ASSESS THE COST-EFFECTIVENESS OF YOGA FOR MANAGING MUSCULOSKELETAL CONDITIONS. METHODS: A RANDOMIZED CONTROLLED TRIAL EVALUATED AN 8-WEEK YOGA PROGRAMME, WITH A 6-MONTH FOLLOW-UP, FOR NATIONAL HEALTH SERVICE (NHS) EMPLOYEES. EFFECTIVENESS IN MANAGING MUSCULOSKELETAL CONDITIONS WAS ASSESSED USING REPEATED-MEASURES GENERALIZED LINEAR MODELLING FOR THE ROLAND-MORRIS DISABILITY QUESTIONNAIRE (RDQ) AND THE KEELE START BACK SCREENING TOOL. COST-EFFECTIVENESS WAS DETERMINED USING AREA-UNDER-THE-CURVE LINEAR REGRESSION FOR ASSESSING HRQL FROM HEALTHCARE AND SOCIETAL PERSPECTIVES. THE INCREMENTAL COST PER QUALITY-ADJUSTED LIFE YEAR (QALY) WAS ALSO CALCULATED. SICKNESS ABSENCE WAS MEASURED USING ELECTRONIC STAFF RECORDS AT 6 MONTHS. RESULTS: THERE WERE 151 PARTICIPANTS. AT 6 MONTHS, MEAN DIFFERENCES BETWEEN GROUPS FAVOURING YOGA WERE OBSERVED FOR RDQ [-0.63 (95% CI, -1.78, 0.48)], KEELE START [-0.28 (95% CI, -0.97, 0.07)] AND HRQL (0.016 QALY GAIN). FROM A HEALTHCARE PERSPECTIVE, YOGA YIELDED AN INCREMENTAL COST-EFFECTIVENESS RATIO OF POUND2103 PER QALY. GIVEN A WILLINGNESS TO PAY FOR AN ADDITIONAL QALY OF POUND20 000, THE PROBABILITY OF YOGA BEING COST-EFFECTIVE WAS 95%. FROM A SOCIETAL PERSPECTIVE, YOGA WAS THE DOMINANT TREATMENT COMPARED WITH USUAL CARE. AT 6 MONTHS, ELECTRONIC STAFF RECORDS SHOWED THAT YOGA PARTICIPANTS MISSED A TOTAL OF 2 WORKING DAYS DUE TO MUSCULOSKELETAL CONDITIONS COMPARED WITH 43 DAYS FOR USUAL CARE PARTICIPANTS. CONCLUSIONS: YOGA FOR NHS EMPLOYEES MAY ENHANCE HRQL, REDUCE DISABILITY ASSOCIATED WITH BACK PAIN, LOWER SICKNESS ABSENCE DUE TO MUSCULOSKELETAL CONDITIONS AND IS LIKELY TO BE COST-EFFECTIVE. 2017 2 294 27 AFFECT AND MINDFULNESS AS PREDICTORS OF CHANGE IN MOOD DISTURBANCE, STRESS SYMPTOMS, AND QUALITY OF LIFE IN A COMMUNITY-BASED YOGA PROGRAM FOR CANCER SURVIVORS. LITTLE ATTENTION HAS BEEN PAID TO THE PSYCHOLOGICAL DETERMINANTS BY WHICH BENEFITS ARE ACCRUED VIA YOGA PRACTICE IN CANCER-RELATED CLINICAL SETTINGS. USING A LONGITUDINAL MULTILEVEL MODELING APPROACH, ASSOCIATIONS BETWEEN AFFECT, MINDFULNESS, AND PATIENT-REPORTED MENTAL HEALTH OUTCOMES, INCLUDING MOOD DISTURBANCE, STRESS SYMPTOMS, AND HEALTH-RELATED QUALITY OF LIFE (HRQL), WERE EXAMINED IN AN EXISTING SEVEN-WEEK YOGA PROGRAM FOR CANCER SURVIVORS. PARTICIPANTS (N = 66) WERE ASSESSED BEFORE AND AFTER THE YOGA PROGRAM AND AT THREE- AND SIX-MONTH FOLLOW-UPS. DECREASES IN MOOD DISTURBANCE AND STRESS SYMPTOMS AND IMPROVEMENTS IN HRQL WERE OBSERVED UPON PROGRAM COMPLETION. IMPROVEMENTS IN MOOD DISTURBANCE AND STRESS SYMPTOMS WERE MAINTAINED AT THE THREE- AND SIX-MONTH FOLLOW-UPS. HRQL EXHIBITED FURTHER IMPROVEMENT AT THE THREE-MONTH FOLLOW-UP, WHICH WAS MAINTAINED AT THE SIX-MONTH FOLLOW-UP. IMPROVEMENTS IN MEASURES OF WELL-BEING WERE PREDICTED BY INITIAL POSITIVE YOGA BELIEFS AND CONCURRENTLY ASSESSED AFFECTIVE AND MINDFULNESS PREDICTOR VARIABLES. PREVIOUS YOGA EXPERIENCE, AFFECT, MINDFULNESS, AND HRQL WERE RELATED TO YOGA PRACTICE MAINTENANCE OVER THE COURSE OF THE STUDY. 2013 3 200 35 A RESPONDER ANALYSIS OF THE EFFECTS OF YOGA FOR INDIVIDUALS WITH COPD: WHO BENEFITS AND HOW? BACKGROUND: WE PREVIOUSLY REPORTED THAT A TWICE-WEEKLY, MODIFIED IYENGAR YOGA PROGRAM WAS A SAFE AND VIABLE SELF-MANAGEMENT STRATEGY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). 1 OBJECTIVE: THE PRIMARY PURPOSE OF THIS EXPLORATORY ANALYSIS WAS TO CLASSIFY YOGA PARTICIPANTS INTO 1 OF 3 RESPONDER CATEGORIES BY USING MINIMUM CLINICALLY IMPORTANT DIFFERENCE (MCID) CRITERIA FOR EACH OF 3 VARIABLES: 6-MINUTE WALK DISTANCE (6MW), DISTRESS RELATED TO DYSPNEA (SHORTNESS OF BREATH; DD), AND FUNCTIONAL PERFORMANCE (FPI). CHANGES IN HEALTH-RELATED QUALITY OF LIFE (HRQL) AND IN PSYCHOLOGICAL WELL-BEING (ANXIETY AND DEPRESSION), AND PARTICIPANTS' SELF-REPORTED IMPROVEMENTS BY RESPONDER CATEGORY WERE ALSO EXAMINED. A SECONDARY GOAL WAS TO IDENTIFY BASELINE PARTICIPANT CHARACTERISTICS, INCLUDING INITIAL RANDOMIZATION ASSIGNMENT THAT MIGHT PREDICT RESPONSE TO TREATMENT. METHODS: PARTICIPANTS WERE RANDOMLY ASSIGNED TO EITHER AN INITIAL YOGA (IY) OR AN ENHANCED WAIT-LIST CONTROL (WLC) GROUP. THOSE IN THE WLC GROUP WERE OFFERED THE YOGA PROGRAM IMMEDIATELY FOLLOWING THE IY GROUP'S PARTICIPATION. INDIVIDUALS FROM BOTH GROUPS WHO COMPLETED AT LEAST 18 OF 24 YOGA CLASSES WERE CATEGORIZED AS RESPONDERS, PARTIAL RESPONDERS, OR NON-RESPONDERS FOR EACH OF THE 3 OUTCOME VARIABLES (6MW, DD, FPI) ON THE BASIS OF MCID CRITERIA. BASELINE CHARACTERISTICS AND CHANGES IN HRQL AND PSYCHOLOGICAL WELL-BEING WERE ALSO ANALYZED. RESULTS: NONE OF THE PARTICIPANTS DEMONSTRATED MCIDS FOR ALL 3 OUTCOMES; HOWEVER, 6 WERE CLASSIFIED AS RESPONDERS FOR 2 OUT-COME VARIABLES AND 4 WERE CLASSIFIED AS NON-RESPONDERS FOR ALL 3 OUTCOME VARIABLES. TWO-THIRDS OF THE FEMALE PARTICIPANT GROUP AND ONE-THIRD OF THE MALE PARTICIPANT GROUP COMPLETED THE YOGA PROGRAM. DD RESPONDERS SHOWED INCREASED ANXIETY LEVELS, WHEREAS ANXIETY LEVELS OF THE DD NON-RESPONDERS REMAINED UNCHANGED. FPI RESPONDERS REPORTED SIGNIFICANT IMPROVEMENTS IN PHYSICAL FUNCTION, WHEREAS PARTIAL AND NON-FPI RESPONDERS NOTED DECLINED FUNCTION. PARTICIPANTS ASSIGNED TO THE IY GROUP DEMONSTRATED GREATER BENEFIT FROM YOGA THAN DID THOSE IN THE W LC GROUP. CONCLUSIONS: ALTHOUGH THIS MODIFIED IYENGAR YOGA PROGRAM APPEARS TO HAVE BENEFITED SOME INDIVIDUALS WITH COPD, FURTHER STUDIES ARE REQUIRED TO ASSESS WHO THE INTERVENTION WORKS FOR AND UNDER WHAT CONDITIONS. 2012 4 2677 35 YOGA IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS. OBJECTIVE: THE OBJECTIVE OF THIS SYSTEMATIC REVIEW WAS TO ASSESS THE EFFECTIVENESS OF YOGA AS A COMPLEMENTARY TREATMENT ON GENERAL PSYCHOPATHOLOGY, POSITIVE AND NEGATIVE SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE (HRQL) FOR PEOPLE WITH SCHIZOPHRENIA. METHOD: RANDOMISED CONTROLLED TRIALS (RCTS) WERE CONSIDERED WHETHER THEY INVESTIGATED A YOGA INTERVENTION IN PATIENTS WITH SCHIZOPHRENIA. THE SELECTION OF STUDIES, DATA EXTRACTION AND QUALITY ASSESSMENT WERE PERFORMED INDEPENDENTLY BY TWO REVIEWERS. RESULTS: ONLY THREE RCTS MET THE INCLUSION CRITERIA. LOWER POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) TOTAL SCORES AND SUBSCALE SCORES FOR POSITIVE AND NEGATIVE SYMPTOMS WERE OBTAINED AFTER YOGA COMPARED WITH EXERCISE OR WAITING LIST CONTROL CONDITIONS. IN THE SAME WAY, THE PHYSICAL, PSYCHOLOGICAL, SOCIAL AND ENVIRONMENTAL HRQL AS MEASURED WITH THE ABBREVIATED VERSION OF THE WORLD HEALTH ORGANIZATION QUALITY OF LIFE QUESTIONNAIRE (WHOQOL-BREF) INCREASED MORE SIGNIFICANTLY AFTER YOGA THAN AFTER EXERCISE OR WAITING LIST CONTROL CONDITIONS. NONE OF THE RCTS ENCOUNTERED ADVERSE EVENTS. DOSE-RESPONSE RELATIONSHIPS COULD, HOWEVER, NOT BE DETERMINED. CONCLUSION: ALTHOUGH THE NUMBER OF RCTS INCLUDED IN THIS REVIEW WAS LIMITED, RESULTS INDICATED THAT YOGA THERAPY CAN BE AN USEFUL ADD-ON TREATMENT TO REDUCE GENERAL PSYCHOPATHOLOGY AND POSITIVE AND NEGATIVE SYMPTOMS. IN THE SAME WAY, HRQL IMPROVED IN THOSE ANTIPSYCHOTIC-STABILISED PATIENTS WITH SCHIZOPHRENIA FOLLOWING YOGA. 2012 5 556 45 COST-EFFECTIVENESS OF EARLY INTERVENTIONS FOR NON-SPECIFIC LOW BACK PAIN: A RANDOMIZED CONTROLLED STUDY INVESTIGATING MEDICAL YOGA, EXERCISE THERAPY AND SELF-CARE ADVICE. OBJECTIVE: TO EVALUATE THE COST-EFFECTIVENESS OF MEDICAL YOGA AS AN EARLY INTERVENTION COMPARED WITH EVIDENCE-BASED EXERCISE THERAPY AND SELF-CARE ADVICE FOR NON-SPECIFIC LOW BACK PAIN. DESIGN: RANDOMIZED CONTROLLED TRIAL WITH A COST-EFFECTIVENESS ANALYSIS. SUBJECTS: A TOTAL OF 159 PARTICIPANTS RANDOMIZED INTO THE MEDICAL YOGA GROUP (N = 52), THE EXERCISE THERAPY GROUP (N = 52) AND THE SELF-CARE ADVICE GROUP (N = 55). METHODS: THE HEALTH OUTCOME MEASURE EQ-5D WAS APPLIED TO MEASURE QUALITY OF LIFE DATA COMBINED WITH COST DATA COLLECTED FROM TREATMENT GROUPS FROM BASELINE TO 12 MONTHS FOLLOW-UP. OUTCOME MEASURE WAS HEALTH-RELATED QUALITY OF LIFE (HRQL). INCREMENTAL COST PER QUALITY ADJUSTED LIFE YEAR (QALY) WAS ALSO CALCULATED. COST-EFFECTIVENESS ANALYSIS WAS CONDUCTED PRIMARILY FROM THE SOCIETAL AND EMPLOYER PERSPECTIVES. RESULTS: MEDICAL YOGA IS COST-EFFECTIVE COMPARED WITH SELF-CARE ADVICE IF AN EMPLOYER CONSIDERS THE SIGNIFICANT IMPROVEMENT IN THE HRQL OF AN EMPLOYEE WITH LOW BACK PAIN JUSTIFIES THE ADDITIONAL COST OF TREATMENT (I.E. IN THIS STUDY EUR 150). FROM A SOCIETAL PERSPECTIVE, MEDICAL YOGA IS A COST-EFFECTIVE TREATMENT COMPARED WITH EXERCISE THERAPY AND SELF-CARE ADVICE IF AN ADDITIONAL QALY IS WORTH EUR 11,500. SENSITIVITY ANALYSIS SUGGESTS THAT MEDICAL YOGA IS MORE COST-EFFECTIVE THAN ITS ALTERNATIVES. CONCLUSION: SIX WEEKS OF UNINTERRUPTED MEDICAL YOGA THERA-PY IS A COST-EFFECTIVE EARLY INTERVENTION FOR NON-SPECIFIC LOW BACK PAIN, WHEN TREATMENT RECOMMENDATIONS ARE ADHERED TO. 2015 6 2683 36 YOGA IN THE MANAGEMENT OF CHRONIC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: HEART DISEASE, STROKE, AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ARE THE LEADING CAUSES OF DEATH AND DISABILITY WORLDWIDE. ALTHOUGH INDIVIDUALS WITH THESE CONDITIONS HAVE BEEN REPORTED TO BENEFIT FROM YOGA, ITS EFFECTIVENESS REMAINS UNCLEAR. OBJECTIVE: TO PERFORM A SYSTEMATIC REVIEW OF THE EFFECTIVENESS OF YOGA ON EXERCISE CAPACITY, HEALTH RELATED QUALITY OF LIFE (HRQL), AND PSYCHOLOGICAL WELL-BEING FOR INDIVIDUALS WITH CHRONIC DISEASE AND DESCRIBE THE STRUCTURE AND DELIVERY OF PROGRAMS. RESEARCH DESIGN: WE PERFORMED A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS EXAMINING YOGA PROGRAMS FOR INDIVIDUALS WITH HEART DISEASE, STROKE, AND COPD COMPARED WITH USUAL CARE. QUALITY WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. META-ANALYSES WERE CONDUCTED USING REVIEW MANAGER 5.3. THE PROTOCOL WAS REGISTERED ON PROSPERO (CRD42014014589). RESULTS: TEN STUDIES (431 INDIVIDUALS, MEAN AGE 56+/-8 Y) WERE INCLUDED AND WERE COMPARABLE IN THEIR DESIGN AND COMPONENTS, IRRESPECTIVE OF THE CHRONIC DISEASE. THE STANDARDIZED MEAN DIFFERENCE FOR THE MEAN CHANGE IN EXERCISE CAPACITY WAS 2.69 (95% CONFIDENCE INTERVAL, 1.39-3.99) AND FOR HRQL IT WAS 1.24 (95% CONFIDENCE INTERVAL, -0.37 TO 2.85). SYMPTOMS OF ANXIETY WERE REDUCED AFTER YOGA IN INDIVIDUALS WITH STROKE, ALTHOUGH THIS WAS NOT OBSERVED IN INDIVIDUALS WITH COPD. THE EFFECT OF YOGA ON SYMPTOMS OF DEPRESSION VARIED ACROSS STUDIES WITH NO SIGNIFICANT EFFECTS COMPARED WITH USUAL CARE. CONCLUSIONS: YOGA PROGRAMS HAVE SIMILAR DESIGNS AND COMPONENTS ACROSS CHRONIC DISEASE POPULATIONS. COMPARED WITH USUAL CARE, YOGA RESULTED IN SIGNIFICANT IMPROVEMENTS IN EXERCISE CAPACITY AND A MEAN IMPROVEMENT IN HRQL. YOGA PROGRAMS MAY BE A USEFUL ADJUNCT TO FORMAL REHABILITATION PROGRAMS. 2015 7 2684 30 YOGA IN THE PEDIATRIC ONCOLOGY POPULATION: A REVIEW OF THE LITERATURE. BACKGROUND: THE PURPOSE OF THIS REVIEW WAS TO EVALUATE THE CURRENT BODY OF LITERATURE ON YOGA IN THE PEDIATRIC ONCOLOGY POPULATION. CONSIDERING THE INCREASING NUMBER OF STUDIES ON YOGA INDICATING IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE (HRQL) AMONG THE ADULT ONCOLOGY POPULATION, IT IS IMPORTANT TO EXPLORE WHETHER SIMILAR BENEFITS HAVE BEEN FOUND IN PEDIATRIC ONCOLOGY PATIENTS. METHODS: CINAHL, OVID MEDLINE, PSYCINFO, PUBMED, AND SCOPUS WERE SEARCHED FROM THE YEARS 2010 THROUGH 2020 FOR STUDIES ASSESSING THE USE OF YOGA IN CHILDREN AND ADOLESCENTS AFFECTED BY CANCER. CONSIDERING THE BENEFITS OF YOGA ON HRQL IN THE ADULT ONCOLOGY POPULATION, THE AIM OF THIS REVIEW WAS TO EVALUATE THE CURRENT BODY OF LITERATURE ON YOGA IN THE PEDIATRIC CANCER POPULATION. RESULTS: EIGHT STUDIES, ALL NONRANDOMIZED WITH SINGLE-ARM DESIGNS, WERE REVIEWED. FIVE OF THE STUDIES WERE DESIGNED AS FEASIBILITY STUDIES AND WHILE RECRUITMENT RATES RANGED FROM 34% TO 55%, RETENTION RATES WERE APPROXIMATELY 70%. QUALITATIVE FEEDBACK FROM PARTICIPANTS WAS VERY POSITIVE AND THEMES RELATED TO BOTH PHYSICAL AND PSYCHOLOGICAL BENEFITS. CERTAIN MEASURES OF HRQL (I.E., ANXIETY, PAIN, AND PHYSICAL FUNCTIONING) WERE FOUND TO BE SIGNIFICANTLY IMPROVED FOLLOWING A YOGA INTERVENTION. DISCUSSION: ALTHOUGH NO RANDOMIZED CLINICAL TRIALS HAVE BEEN CONDUCTED TO DATE ON THIS IMPORTANT TOPIC, THE STUDIES REVIEWED SHOWED THAT DELIVERING YOGA TO THIS POPULATION IS FEASIBLE AND SAFE. ADDITIONALLY, PRELIMINARY FINDINGS ON THE IMPACT OF YOGA FOR SOME OF THE COMMON SYMPTOMS AND TREATMENT-RELATED SIDE EFFECTS EXPERIENCED BY CHILDREN AND ADOLESCENTS AFFECTED BY CANCER ARE PROMISING. 2021 8 2207 29 THE FEASIBILITY AND BENEFITS OF A 12-WEEK YOGA INTERVENTION FOR PEDIATRIC CANCER OUT-PATIENTS. BACKGROUND: INCREASING RATES OF SURVIVAL PRESENT A NEW SET OF PSYCHOSOCIAL AND PHYSICAL CHALLENGES FOR CHILDREN UNDERGOING TREATMENT FOR CANCER. PHYSICAL ACTIVITY (PA) HAS BEEN SHOWN TO BE A SAFE AND EFFECTIVE STRATEGY TO MITIGATE THE SIGNIFICANT BURDEN OF CANCER AND ITS TREATMENTS, WITH YOGA INCREASINGLY GAINING RECOGNITION AS A GENTLE ALTERNATIVE. THE PURPOSE OF THIS STUDY WAS TO DETERMINE THE FEASIBILITY AND BENEFITS OF A 12-WEEK COMMUNITY-BASED YOGA INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE (HRQL), SELECT PHYSICAL FITNESS OUTCOMES AND PA LEVELS (PAL). PROCEDURE: EIGHT PEDIATRIC CANCER OUT-PATIENTS (4 MALE; 4 FEMALE; MAGE = 11.88, SD = 4.26) PARTICIPATED IN THE 12-WEEK INTERVENTION CONSISTING OF SUPERVISED YOGA SESSIONS 2 TIMES/WEEK. PARTICIPANTS (PATIENTS AND PARENT PROXIES) COMPLETED MEASURES ASSESSING HRQL, PHYSICAL FITNESS AND PAL AT BASELINE AND POST-INTERVENTION. RESULTS: RATES OF RECRUITMENT, RETENTION, ATTENDANCE AND ADVERSE EVENTS INDICATED THE PROGRAM WAS FEASIBLE. WILCOXON SIGNED RANK TESTS INDICATED SIGNIFICANT IMPROVEMENTS FOR PATIENT (P = 0.02) AND PARENT REPORTED HRQL (P = 0.03), FUNCTIONAL MOBILITY (P = 0.01), HAMSTRING FLEXIBILITY (LEFT, P = 0.01 AND RIGHT P = 0.02), AND TOTAL PAL (P = 0.02) PRE TO POST INTERVENTION. CONCLUSION: THIS 12-WEEK COMMUNITY-BASED YOGA INTERVENTION WAS FEASIBLE AND PROVIDES PRELIMINARY EVIDENCE FOR THE BENEFITS OF YOGA ON HRQL, PHYSICAL FITNESS AND PAL IN PEDIATRIC CANCER OUT-PATIENTS. IN A POPULATION WHERE SEDENTARY BEHAVIOR AND THE ASSOCIATED CO-MORBIDITIES ARE A GROWING CONCERN, THESE RESULTS PROMOTE THE CONTINUED EXPLORATION OF YOGA PROGRAMMING. 2014 9 2860 36 YOGA-BASED EXERCISE IMPROVES HEALTH-RELATED QUALITY OF LIFE AND MENTAL WELL-BEING IN OLDER PEOPLE: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS. OBJECTIVE: HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND MENTAL WELL-BEING ARE ASSOCIATED WITH HEALTHY AGEING. PHYSICAL ACTIVITY POSITIVELY IMPACTS BOTH HRQOL AND MENTAL WELL-BEING. YOGA IS A PHYSICAL ACTIVITY THAT CAN BE MODIFIED TO SUITS THE NEEDS OF OLDER PEOPLE AND IS GROWING IN POPULARITY. WE CONDUCTED A SYSTEMATIC REVIEW WITH META-ANALYSIS TO DETERMINE THE IMPACT OF YOGA-BASED EXERCISE ON HRQOL AND MENTAL WELL-BEING IN PEOPLE AGED 60+. METHODS: SEARCHES WERE CONDUCTED FOR RELEVANT TRIALS IN THE FOLLOWING ELECTRONIC DATABASES; MEDLINE, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, CINAHL, ALLIED AND COMPLEMENTARY MEDICINE DATABASE, PSYCINFO AND THE PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO) FROM INCEPTION TO JANUARY 2017. TRIALS THAT EVALUATED THE EFFECT OF PHYSICAL YOGA ON HRQOL AND/OR ON MENTAL WELL-BEING IN PEOPLE AGED 60+ YEARS WERE INCLUDED. DATA ON HRQOL AND MENTAL WELL-BEING WERE EXTRACTED. STANDARDISED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING RANDOM EFFECTS MODELS. METHODOLOGICAL QUALITY OF TRIALS WAS ASSESSED USING THE PEDRO SCALE. RESULTS: TWELVE TRIALS OF HIGH METHODOLOGICAL QUALITY (MEAN PEDRO SCORE 6.1), TOTALLING 752 PARTICIPANTS, WERE IDENTIFIED AND PROVIDED DATA FOR THE META-ANALYSIS. YOGA PRODUCED A MEDIUM EFFECT ON HRQOL (HEDGES' G = 0.51, 95% CI 0.25-0.76, 12 TRIALS) AND A SMALL EFFECT ON MENTAL WELL-BEING (HEDGES' G = 0.38, 95% CI 0.15-0.62, 12 TRIALS). CONCLUSION: YOGA INTERVENTIONS RESULTED IN SMALL TO MODERATE IMPROVEMENTS IN BOTH HRQOL AND MENTAL WELL-BEING IN PEOPLE AGED 60+ YEARS. FURTHER, RESEARCH IS NEEDED TO DETERMINE THE OPTIMAL DOSE OF YOGA TO MAXIMISE HEALTH IMPACT. PROSPERO REGISTRATION NUMBER: (CRD42016052458). 2018 10 1379 35 IMPACT OF IYENGAR YOGA ON QUALITY OF LIFE IN YOUNG WOMEN WITH RHEUMATOID ARTHRITIS. OBJECTIVE: RHEUMATOID ARTHRITIS (RA) IS A CHRONIC, DISABLING DISEASE THAT CAN GREATLY COMPROMISE HEALTH-RELATED QUALITY OF LIFE (HRQOL). THE AIM OF THIS STUDY WAS TO ASSESS THE IMPACT OF A 6-WEEK TWICE/WEEK IYENGAR YOGA PROGRAM ON HRQOL OF YOUNG ADULTS WITH RA COMPARED WITH A USUAL-CARE WAITLIST CONTROL GROUP. METHODS: THE PROGRAM WAS DESIGNED TO IMPROVE THE PRIMARY OUTCOME OF HRQOL INCLUDING PAIN AND DISABILITY AND PSYCHOLOGICAL FUNCTIONING IN PATIENTS. ASSESSMENTS WERE COLLECTED PRETREATMENT, POSTTREATMENT, AND AT 2 MONTHS AFTER TREATMENT. WEEKLY RATINGS OF ANXIETY, DEPRESSION, PAIN, AND SLEEP WERE ALSO RECORDED. A TOTAL OF 26 PARTICIPANTS COMPLETED THE INTERVENTION (YOGA=11; USUAL-CARE WAITLIST=15). ALL PARTICIPANTS WERE FEMALE (MEAN AGE=28 Y). RESULTS: OVERALL ATTRITION WAS LOW AT 15%. ON AVERAGE, WOMEN IN THE YOGA GROUP ATTENDED 96% OF THE YOGA CLASSES. NO ADVERSE EVENTS WERE REPORTED. RELATIVE TO THE USUAL-CARE WAITLIST, WOMEN ASSIGNED TO THE YOGA PROGRAM SHOWED SIGNIFICANTLY GREATER IMPROVEMENT ON STANDARDIZED MEASURES OF HRQOL, PAIN DISABILITY, GENERAL HEALTH, MOOD, FATIGUE, ACCEPTANCE OF CHRONIC PAIN, AND SELF-EFFICACY REGARDING PAIN AT POSTTREATMENT. ALMOST HALF OF THE YOGA GROUP REPORTED CLINICALLY MEANINGFUL SYMPTOM IMPROVEMENT. ANALYSIS OF THE UNCONTROLLED EFFECTS AND MAINTENANCE OF TREATMENT EFFECTS SHOWED IMPROVEMENTS IN HRQOL GENERAL HEALTH, PAIN DISABILITY, AND WEEKLY RATINGS OF PAIN, ANXIETY, AND DEPRESSION WERE MAINTAINED AT FOLLOW-UP. CONCLUSIONS: THE FINDINGS SUGGEST THAT A BRIEF IYENGAR YOGA INTERVENTION IS A FEASIBLE AND SAFE ADJUNCTIVE TREATMENT FOR YOUNG PEOPLE WITH RA, LEADING TO HRQOL, PAIN DISABILITY, FATIGUE, AND MOOD BENEFITS. MOREOVER, IMPROVEMENTS IN QUALITY OF LIFE, PAIN DISABILITY, AND MOOD PERSISTED AT THE 2-MONTH FOLLOW-UP. 2013 11 1061 39 EFFECTS OF YOGA ON HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: YOGA RECEIVE MORE ATTENTION FROM BREAST CANCER PATIENTS, HOWEVER ITS FEASIBILITY AND EFFICACY DURING CHEMOTHERAPY REMAINS CONFLICTING. WE PERFORMED THIS SYSTEMATIC REVIEW TO ASSESS THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY. METHODS: A SYSTEMATIC SEARCH WAS CONDUCTED TO RETRIEVE RANDOMIZED CONTROLLED TRIALS (RCTS) WHICH INVESTIGATED THE COMPARATIVE EFFICACY OF YOGA VERSUS COMPARATORS SUCH AS USUAL CARE AMONG BREAST CANCER PATIENTS FOR HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN PUBMED, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CNETRAL), NURSING AND ALLIED HEALTH LITERATURE (CINAHL), CHINESE BIOMEDICAL LITERATURE (CBM) DATABASE, CHINA SCIENCE AND TECHNOLOGY JOURNAL (CSTJ) DATABASE, CHINA NATIONAL KNOWLEDGE INFRASTRUCTURE (CNKI), AND WANGFANG DATABASE FROM INCEPTION TO DECEMBER 2018. THE LATEST SEARCH WAS UPDATED ON SEPTEMBER 2020. ALL ANALYSES WERE COMPLETED USING REVMAN VERSION 5.3. RESULTS: SEVEN TRIALS INVOLVING 693 BREAST CANCER PATIENTS MET INCLUSION CRITERIA. META-ANALYSIS INDICATED A SHORT-TERM IMPROVEMENT IN FATIGUE [STANDARD MEAN DIFFERENCE (SMD), -0.62; 95% CONFIDENCE INTERVAL (CI), -1.17 TO -0.07], SLEEP DISTURBANCE (SMD, -0.34; 95% CI, -0.55 TO -0.12), DEPRESSION (SMD, -0.50; 95% CI, -0.70 TO -0.31) ANXIETY (SMD, -0.50; 95% CI, -0.70 TO -0.31), AND HEALTH-RELATED QUALITY OF LIFE (QOL) (SMD, 0.72; 95% CI, -0.12 TO 1.56) IN THE YOGA GROUP; HOWEVER BENEFICIAL MEDIUM- AND LONG-TERM EFFECTS IN FATIGUE, SLEEP DISTURBANCE WERE NOT IDENTIFIED. MOREOVER, QUALITATIVE ANALYSES SUGGESTED THAT YOGA WAS NOT ASSOCIATED WITH DECREASED ADVERSE EVENTS (AES) COMPARED WITH CONTROL GROUPS. CONCLUSIONS: YOGA MAY BENEFIT TO REDUCE FATIGUE, DEPRESSION AND ANXIETY, IMPROVE SLEEP DISTURBANCE, AND IMPROVE QOL IN BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY IN THE SHORT-TERM; HOWEVER, MEDIUM- AND LONG-TERM EFFECTS SHOULD BE FURTHER ESTABLISHED OWING TO LIMITATIONS. 2021 12 2787 28 YOGA THERAPY DECREASES DYSPNEA-RELATED DISTRESS AND IMPROVES FUNCTIONAL PERFORMANCE IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A PILOT STUDY. BACKGROUND: THERE HAS BEEN LIMITED STUDY OF YOGA TRAINING AS A COMPLEMENTARY EXERCISE STRATEGY TO MANAGE THE SYMPTOM OF DYSPNEA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). PURPOSE: THE PRIMARY PURPOSE OF THIS PILOT STUDY WAS TO EVALUATE A YOGA PROGRAM FOR ITS SAFETY, FEASIBILITY, AND EFFICACY FOR DECREASING DYSPNEA INTENSITY (DI) AND DYSPNEA-RELATED DISTRESS (DD) IN OLDER ADULTS WITH COPD. METHODS: CLINICALLY STABLE PATIENTS WITH COPD (N = 29; AGE 69.9 +/- 9.5; FORCED EXPIRATORY VOLUME IN 1 SECOND (FEV(1)) 47.7 +/- 15.6% PREDICTED; FEMALE = 21) WERE RANDOMIZED TO A 12-WEEK YOGA PROGRAM SPECIFICALLY DESIGNED FOR PEOPLE WITH COPD OR USUAL-CARE CONTROL (UC). THE TWICE-WEEKLY YOGA PROGRAM INCLUDED ASANAS (YOGA POSTURES) AND VISAMA VRITTI PRANAYAMA (TIMED BREATHING). SAFETY MEASURE OUTCOMES INCLUDED HEART RATE, OXYGEN SATURATION, DYSPNEA, AND PAIN. FEASIBILITY WAS MEASURED BY PATIENT-REPORTED ENJOYMENT, DIFFICULTY, AND ADHERENCE TO YOGA SESSIONS. AT BASELINE AND AT 12 WEEKS, DI AND DD WERE MEASURED DURING INCREMENTAL CYCLE ERGOMETRY AND A 6-MINUTE WALK (6MW) TEST. SECONDARY EFFICACY OUTCOMES INCLUDED PHYSICAL PERFORMANCE, PSYCHOLOGIC WELL-BEING, AND HEALTH-RELATED QUALITY OF LIFE (HRQOL). RESULTS: YOGA TRAINING WAS SAFE AND FEASIBLE FOR PATIENTS WITH COPD. WHILE YOGA TRAINING HAD ONLY SMALL EFFECTS ON DI AFTER THE 6MW TEST (EFFECT SIZE [ES], 0.20; P = 0.60), THERE WERE GREATER REDUCTIONS IN DD IN THE YOGA GROUP COMPARED TO UC (ES, 0.67; P = 0.08). YOGA TRAINING ALSO IMPROVED 6MW DISTANCE (+71.7 +/- 21.8 FEET VERSUS -27.6 +/- 36.2 FEET; ES = 0.78, P = 0.04) AND SELF-REPORTED FUNCTIONAL PERFORMANCE (ES = 0.79, P = 0.04) COMPARED TO UC. THERE WERE SMALL POSITIVE CHANGES IN MUSCLE STRENGTH AND HRQOL. CONCLUSIONS: ELDERLY PATIENTS WITH COPD PARTICIPATED SAFELY IN A 12-WEEK YOGA PROGRAM ESPECIALLY DESIGNED FOR PATIENTS WITH THIS CHRONIC ILLNESS. AFTER THE PROGRAM, THE SUBJECTS TOLERATED MORE ACTIVITY WITH LESS DD AND IMPROVED THEIR FUNCTIONAL PERFORMANCE. THESE FINDINGS NEED TO BE CONFIRMED IN A LARGER, MORE SUFFICIENTLY POWERED EFFICACY STUDY. 2009 13 1054 38 EFFECTS OF YOGA ON CHRONIC NECK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTIVENESS OF YOGA IN RELIEVING CHRONIC NECK PAIN. METHODS: PUBMED/MEDLINE, THE COCHRANE LIBRARY, SCOPUS, AND INDMED WERE SCREENED THROUGH JANUARY 2017 FOR RANDOMIZED CONTROLLED TRIALS ASSESSING NECK PAIN INTENSITY AND/OR NECK PAIN-RELATED DISABILITY IN CHRONIC NECK PAIN PATIENTS. SECONDARY OUTCOME MEASURES INCLUDED QUALITY OF LIFE, MOOD, AND SAFETY. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: THREE STUDIES ON 188 PATIENTS WITH CHRONIC NON-SPECIFIC NECK PAIN COMPARING YOGA TO USUAL CARE WERE INCLUDED. TWO STUDIES HAD OVERALL LOW RISK OF BIAS; AND ONE HAD HIGH OR UNCLEAR RISK OF BIAS FOR SEVERAL DOMAINS. EVIDENCE FOR SHORT-TERM EFFECTS WAS FOUND FOR NECK PAIN INTENSITY (STANDARDIZED MEAN DIFFERENCE (SMD) = -1.28; 95% CONFIDENCE INTERVAL (CI) = -1.18, -0.75; P < 0.001), NECK PAIN-RELATED DISABILITY (SMD = -0.97; 95% CI = -1.44, -0.50; P < 0.001), QUALITY OF LIFE (SMD = 0.57; 95% CI = 0.17, 0.197; P = 0.005), AND MOOD (SMD = -1.02; 95% CI = -1.38, -0.65; P < 0.001). EFFECTS WERE ROBUST AGAINST POTENTIAL METHODOLOGICAL BIAS AND DID NOT DIFFER BETWEEN DIFFERENT INTERVENTION SUBGROUPS. IN THE TWO STUDIES THAT INCLUDED SAFETY DATA, NO SERIOUS ADVERSE EVENTS OCCURRED. CONCLUSION: YOGA HAS SHORT-TERM EFFECTS ON CHRONIC NECK PAIN, ITS RELATED DISABILITY, QUALITY OF LIFE, AND MOOD SUGGESTING THAT YOGA MIGHT BE A GOOD TREATMENT OPTION. 2017 14 1748 31 PILOT RANDOMIZED, CONTROLLED TRIAL OF A DYADIC YOGA PROGRAM FOR GLIOMA PATIENTS UNDERGOING RADIOTHERAPY AND THEIR FAMILY CAREGIVERS. BACKGROUND: WHILE THE USE OF BEHAVIORAL MEDICINE IN MANAGING GLIOMA PATIENTS' SYMPTOMS IS NOT WELL STUDIED, THE HIGH SYMPTOM BURDEN IN PATIENTS AND THEIR FAMILY CAREGIVERS IS WELL ESTABLISHED. WE CONDUCTED A PILOT RANDOMIZED, CONTROLLED TRIAL TO EXAMINE THE FEASIBILITY AND PRELIMINARY EFFICACY OF A DYADIC YOGA (DY) INTERVENTION AS A SUPPORTIVE CARE STRATEGY. METHODS: GLIOMA PATIENTS UNDERGOING RADIOTHERAPY AND THEIR CAREGIVERS WERE RANDOMIZED TO A 12-SESSION DY OR WAITLIST CONTROL (WLC) GROUP. PRIOR TO RADIOTHERAPY AND RANDOMIZATION, BOTH GROUPS COMPLETED MEASURES OF CANCER-RELATED SYMPTOMS (MD ANDERSON SYMPTOM INVENTORY-BRAIN TUMOR MODULE), DEPRESSIVE SYMPTOMS (CENTER FOR EPIDEMIOLOGICAL STUDIES-DEPRESSION MEASURE), FATIGUE (BRIEF FATIGUE INVENTORY), AND OVERALL QUALITY OF LIFE (QOL; MEDICAL OUTCOMES STUDY 36-ITEM SHORT-FORM SURVEY). DYADS WERE REASSESSED AT THE LAST DAY OF RADIOTHERAPY. RESULTS: TWENTY PATIENTS (MEAN AGE: 46 YEARS, 50% FEMALE, 80% WHO GRADE IV AND CAREGIVERS (MEAN AGE: 50 YEARS, 70% FEMALE, 50% SPOUSES) PARTICIPATED IN THE TRIAL. A PRIORI FEASIBILITY CRITERIA WERE MET REGARDING CONSENT (70%), ADHERENCE (88%), AND RETENTION (95%) RATES. CONTROLLING FOR RELEVANT COVARIATES, CHANGE SCORE ANALYSES REVEALED CLINICALLY SIGNIFICANT IMPROVEMENTS FOR PATIENTS IN THE DY COMPARED WITH THE WLC GROUP FOR OVERALL CANCER SYMPTOM SEVERITY (D = 0.96) AND SYMPTOM INTERFERENCE (D = 0.74), DEPRESSIVE SYMPTOMS (D = 0.71), AND MENTAL QOL (D = 0.69). CAREGIVERS IN THE DY GROUP REPORTED CLINICALLY SIGNIFICANT IMPROVEMENTS IN DEPRESSIVE SYMPTOMS (D = 1.12), FATIGUE (D = 0.89), AND MENTAL QOL (D = 0.49) RELATIVE TO THOSE IN THE WLC GROUP. CONCLUSION: A DY INTERVENTION APPEARS TO BE A FEASIBLE AND BENEFICIAL SYMPTOM AND QOL MANAGEMENT STRATEGY FOR GLIOMA PATIENTS UNDERGOING RADIOTHERAPY AND THEIR CAREGIVERS. AN EFFICACY TRIAL WITH A MORE STRINGENT CONTROL GROUP IS WARRANTED. CLINICAL TRIAL NUMBER: NCT02481349. 2019 15 1434 37 IMPROVING VASOMOTOR SYMPTOMS; PSYCHOLOGICAL SYMPTOMS; AND HEALTH-RELATED QUALITY OF LIFE IN PERI- OR POST-MENOPAUSAL WOMEN THROUGH YOGA: AN UMBRELLA SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES: VASOMOTOR SYMPTOMS (VMS), COMMONLY REPORTED DURING MENOPAUSAL TRANSITION, NEGATIVELY AFFECT PSYCHOLOGICAL HEALTH AND HEALTH-RELATED QUALITY OF LIFE (HRQOL). WHILE HORMONE THERAPY IS AN EFFECTIVE TREATMENT, ITS USE IS LIMITED BY CONCERNS ABOUT POSSIBLE HARMS. THUS, MANY WOMEN WITH VMS SEEK NONHORMONAL, NONPHARMACOLOGIC TREATMENT OPTIONS. HOWEVER, EVIDENCE TO GUIDE CLINICAL RECOMMENDATIONS IS INCONCLUSIVE. THIS STUDY REVIEWED THE EFFECTIVENESS OF YOGA, TAI CHI AND QIGONG ON VASOMOTOR, PSYCHOLOGICAL SYMPTOMS, AND HRQOL IN PERI- OR POST-MENOPAUSAL WOMEN. DESIGN: MEDLINE, COCHRANE DATABASE OF SYSTEMATIC REVIEWS, EMBASE, CINAHL AND THE ALLIED AND COMPLEMENTARY MEDICINE DATABASE WERE SEARCHED. RESEARCHERS IDENTIFIED SYSTEMATIC REVIEWS (SR) OR RCTS THAT EVALUATED YOGA, TAI CHI, OR QIGONG FOR VASOMOTOR, PSYCHOLOGICAL SYMPTOMS, AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PERI- OR POST-MENOPAUSAL WOMEN. DATA WERE ABSTRACTED ON STUDY DESIGN, PARTICIPANTS, INTERVENTIONS AND OUTCOMES. RISK OF BIAS (ROB) WAS ASSESSED AND UPDATED META-ANALYSES WERE PERFORMED. RESULTS: WE IDENTIFIED ONE HIGH-QUALITY SR (5 RCTS, 582 PARTICIPANTS) AND 3 NEW RCTS (345 PARTICIPANTS) PUBLISHED AFTER THE SR EVALUATING YOGA FOR VASOMOTOR, PSYCHOLOGICAL SYMPTOMS, AND HRQOL; NO STUDIES EVALUATED TAI CHI OR QIGONG. UPDATED META-ANALYSES INDICATE THAT, COMPARED TO CONTROLS, YOGA REDUCED VMS (5 TRIALS, STANDARDIZED MEAN DIFFERENCE (SMD) -0.27, 95% CI -0.49 TO -0.05) AND PSYCHOLOGICAL SYMPTOMS (6 TRIALS, SDM -0.32; 95% CI -0.47 TO -0.17). EFFECTS ON QUALITY OF LIFE WERE REPORTED INFREQUENTLY. KEY LIMITATIONS ARE THAT ADVERSE EFFECTS WERE RARELY REPORTED AND OUTCOME MEASURES LACKED STANDARDIZATION. CONCLUSIONS: RESULTS FROM THIS META-ANALYSIS SUGGEST THAT YOGA MAY BE A USEFUL THERAPY TO MANAGE BOTHERSOME VASOMOTOR AND PSYCHOLOGICAL SYMPTOMS. 2017 16 2518 52 YOGA COMPARED TO NON-EXERCISE OR PHYSICAL THERAPY EXERCISE ON PAIN, DISABILITY, AND QUALITY OF LIFE FOR PATIENTS WITH CHRONIC LOW BACK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: CHRONIC LOW BACK PAIN (CLBP) IS A COMMON AND OFTEN DISABLING MUSCULOSKELETAL CONDITION. YOGA HAS BEEN PROVEN TO BE AN EFFECTIVE THERAPY FOR CHRONIC LOW BACK PAIN. HOWEVER, THERE ARE STILL CONTROVERSIES ABOUT THE EFFECTS OF YOGA AT DIFFERENT FOLLOW-UP PERIODS AND COMPARED WITH OTHER PHYSICAL THERAPY EXERCISES. OBJECTIVE: TO CRITICALLY COMPARE THE EFFECTS OF YOGA FOR PATIENTS WITH CHRONIC LOW BACK PAIN ON PAIN, DISABILITY, QUALITY OF LIFE WITH NON-EXERCISE (E.G. USUAL CARE, EDUCATION), PHYSICAL THERAPY EXERCISE. METHODS: THIS STUDY WAS REGISTERED IN PROSPERO, AND THE REGISTRATION NUMBER WAS CRD42020159865. RANDOMIZED CONTROLLED TRIALS (RCTS) OF ONLINE DATABASES INCLUDED PUBMED, WEB OF SCIENCE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, EMBASE WHICH EVALUATED EFFECTS OF YOGA FOR PATIENTS WITH CHRONIC LOW BACK PAIN ON PAIN, DISABILITY, AND QUALITY OF LIFE WERE SEARCHED FROM INCEPTION TIME TO NOVEMBER 1, 2019. STUDIES WERE ELIGIBLE IF THEY ASSESSED AT LEAST ONE IMPORTANT OUTCOME, NAMELY PAIN, BACK-SPECIFIC DISABILITY, QUALITY OF LIFE. THE COCHRANE RISK OF BIAS TOOL WAS USED TO ASSESS THE METHODOLOGICAL QUALITY OF INCLUDED RANDOMIZED CONTROLLED TRIALS. THE CONTINUOUS OUTCOMES WERE ANALYZED BY CALCULATING THE MEAN DIFFERENCE (MD) OR STANDARDIZED MEAN DIFFERENCE (SMD) WITH 95% CONFIDENCE INTERVALS (CI) ACCORDING TO WHETHER COMBINING OUTCOMES MEASURED ON DIFFERENT SCALES OR NOT. RESULTS: A TOTAL OF 18 RANDOMIZED CONTROLLED TRIALS WERE INCLUDED IN THIS META-ANALYSIS. YOGA COULD SIGNIFICANTLY REDUCE PAIN AT 4 TO 8 WEEKS (MD = -0.83, 95% CI = -1.19 TO -0.48, P<0.00001, I2 = 0%), 3 MONTHS (MD = -0.43, 95% CI = -0.64 TO -0.23, P<0.0001, I2 = 0%), 6 TO 7 MONTHS (MD = -0.56, 95% CI = -1.02 TO -0.11, P = 0.02, I2 = 50%), AND WAS NOT SIGNIFICANT IN 12 MONTHS (MD = -0.52, 95% CI = -1.64 TO 0.59, P = 0.36, I2 = 87%) COMPARED WITH NON-EXERCISE. YOGA WAS BETTER THAN NON-EXERCISE ON DISABILITY AT 4 TO 8 WEEKS (SMD = -0.30, 95% CI = -0.51 TO -0.10, P = 0.003, I2 = 0%), 3 MONTHS (SMD = -0.31, 95% CI = -0.45 TO -0.18, P<0.00001, I2 = 30%), 6 MONTHS (SMD = -0.38, 95% CI = -0.53 TO -0.23, P<0.00001, I2 = 0%), 12 MONTHS (SMD = -0.33, 95% CI = -0.54 TO -0.12, P = 0.002, I2 = 9%). THERE WAS NO SIGNIFICANT DIFFERENCE ON PAIN, DISABILITY COMPARED WITH PHYSICAL THERAPY EXERCISE GROUP. FURTHERMORE, IT SUGGESTED THAT THERE WAS A NON-SIGNIFICANT DIFFERENCE ON PHYSICAL AND MENTAL QUALITY OF LIFE BETWEEN YOGA AND ANY OTHER INTERVENTIONS. CONCLUSION: THIS META-ANALYSIS PROVIDED EVIDENCE FROM VERY LOW TO MODERATE INVESTIGATING THE EFFECTIVENESS OF YOGA FOR CHRONIC LOW BACK PAIN PATIENTS AT DIFFERENT TIME POINTS. YOGA MIGHT DECREASE PAIN FROM SHORT TERM TO INTERMEDIATE TERM AND IMPROVE FUNCTIONAL DISABILITY STATUS FROM SHORT TERM TO LONG TERM COMPARED WITH NON-EXERCISE (E.G. USUAL CARE, EDUCATION). YOGA HAD THE SAME EFFECT ON PAIN AND DISABILITY AS ANY OTHER EXERCISE OR PHYSICAL THERAPY. YOGA MIGHT NOT IMPROVE THE PHYSICAL AND MENTAL QUALITY OF LIFE BASED ON THE RESULT OF A MERGING. 2020 17 2851 45 YOGA, PHYSICAL THERAPY, AND BACK PAIN EDUCATION FOR SLEEP QUALITY IN LOW-INCOME RACIALLY DIVERSE ADULTS WITH CHRONIC LOW BACK PAIN: A SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: POOR SLEEP IS COMMON AMONG ADULTS WITH CHRONIC LOW BACK PAIN (CLBP), BUT THE INFLUENCE OF CLBP TREATMENTS, SUCH AS YOGA AND PHYSICAL THERAPY (PT), ON SLEEP QUALITY IS UNDER STUDIED. OBJECTIVE: EVALUATE THE EFFECTIVENESS OF YOGA AND PT FOR IMPROVING SLEEP QUALITY IN ADULTS WITH CLBP. DESIGN: SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. SETTING: ACADEMIC SAFETY-NET HOSPITAL AND 7 AFFILIATED COMMUNITY HEALTH CENTERS. PARTICIPANTS: A TOTAL OF 320 ADULTS WITH CLBP. INTERVENTION: TWELVE WEEKLY YOGA CLASSES, 1-ON-1 PT SESSIONS, OR AN EDUCATIONAL BOOK. MAIN MEASURES: SLEEP QUALITY WAS MEASURED USING THE PITTSBURGH SLEEP QUALITY INDEX (PSQI) GLOBAL SCORE (0-21) AT BASELINE, 12 WEEKS, AND 52 WEEKS. ADDITIONALLY, WE ALSO EVALUATED HOW THE PROPORTION OF PARTICIPANTS WHO ACHIEVED A CLINICALLY MEANINGFUL IMPROVEMENT IN SLEEP QUALITY (> 3-POINT REDUCTION IN PSQI) AT 12 WEEKS VARIED BY CHANGES IN PAIN AND PHYSICAL FUNCTION AT 6 WEEKS. KEY RESULTS: AMONG PARTICIPANTS (MEAN AGE = 46.0, 64% FEMALE, 82% NON-WHITE), NEARLY ALL (92%) REPORTED POOR SLEEP QUALITY (PSQI > 5) AT BASELINE. AT 12 WEEKS, MODEST IMPROVEMENTS IN SLEEP QUALITY WERE OBSERVED AMONG THE YOGA (PSQI MEAN DIFFERENCE [MD] = - 1.19, 95% CONFIDENCE INTERVAL [CI] - 1.82, - 0.55) AND PT (PSQI MD = - 0.91, 95% CI - 1.61, - 0.20) GROUPS. PARTICIPANTS WHO REPORTED A >/= 30% IMPROVEMENT IN PAIN OR PHYSICAL FUNCTION AT 6 WEEKS, COMPARED WITH THOSE WHO IMPROVED < 10%, WERE MORE LIKELY TO BE A SLEEP QUALITY RESPONDER AT 12 WEEKS (ODDS RATIO [OR] = 3.51, 95% CI 1.73, 7.11 AND OR = 2.16, 95% CI 1.18, 3.95, RESPECTIVELY). RESULTS WERE SIMILAR AT 52 WEEKS. CONCLUSION: IN A SAMPLE OF ADULTS WITH CLBP, VIRTUALLY ALL WITH POOR SLEEP QUALITY PRIOR TO INTERVENTION, MODEST BUT STATISTICALLY SIGNIFICANT IMPROVEMENTS IN SLEEP QUALITY WERE OBSERVED WITH BOTH YOGA AND PT. IRRESPECTIVE OF TREATMENT, CLINICALLY IMPORTANT SLEEP IMPROVEMENTS AT THE END OF THE INTERVENTION WERE ASSOCIATED WITH MID-INTERVENTION PAIN AND PHYSICAL FUNCTION IMPROVEMENTS. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT01343927. 2020 18 1746 32 PILOT EVALUATION OF AN IYENGAR YOGA PROGRAM FOR BREAST CANCER SURVIVORS. BACKGROUND: WITH CONTINUAL IMPROVEMENTS IN SCREENING UPTAKE AND ADJUVANT CANCER TREATMENTS, THE NUMBER OF CANADIAN WOMEN SURVIVING BREAST CANCER CONTINUES TO GROW. PRELIMINARY FINDINGS SUGGEST YOGA CAN IMPROVE QUALITY OF LIFE (QOL) IN BREAST CANCER SURVIVORS, BUT FEW STUDIES HAVE FOCUSED ON IYENGAR YOGA (IY). OBJECTIVE: THE PURPOSE OF THIS PILOT STUDY WAS TO EVALUATE THE IMPACT OF IY ON QOL AND PSYCHOSOCIAL FUNCTIONING IN A SELECT SAMPLE OF BREAST CANCER SURVIVORS. METHODS: BREAST CANCER SURVIVORS (N = 24) PARTICIPATING IN IY CLASSES COMPLETED A QUESTIONNAIRE MEASURING GENERIC AND DISEASE-SPECIFIC QOL AND PSYCHOSOCIAL FUNCTIONING, BEFORE AND AFTER THE 12-WEEK CLASSES. RESULTS: POSTPROGRAM QUESTIONNAIRES WERE COMPLETED BY 17 PARTICIPANTS (71%) WHO ATTENDED AN AVERAGE OF 78.9% OF THE IY SESSIONS. SEVERAL INDICATORS OF GENERIC QOL IMPROVED SIGNIFICANTLY, INCLUDING MENTAL HEALTH (MEAN CHANGE, +4.2; P = .045), VITALITY (MEAN CHANGE, +4.9; P = .033), ROLE-EMOTIONAL (MEAN CHANGE, +6.4; P = .010), AND BODILY PAIN (MEAN CHANGE, +4.4; P = .024). OTHER IMPROVEMENTS IN QOL AND PSYCHOSOCIAL FUNCTIONING WERE MEANINGFUL BUT WERE NOT STATISTICALLY SIGNIFICANT. FINDINGS WERE FURTHER SUBSTANTIATED BY PARTICIPANT'S EVALUATION OF THE PROGRAM'S BENEFITS AND MOTIVATIONAL VALUE. CONCLUSION: IN THIS PILOT STUDY OF BREAST CANCER SURVIVORS PARTICIPATING IN IY, WE FOUND IMPROVEMENTS IN QOL AND PSYCHOSOCIAL FUNCTIONING. MOREOVER, POSITIVE PROGRAM EVALUATION AND MOTIVATIONAL PROFILE PROVIDE SUPPORT FOR THE ACCEPTABILITY OF IY WITH BREAST CANCER SURVIVORS. RANDOMIZED CONTROLLED TRIALS COMPARING IY TO USUAL CARE AND OTHER FORMS OF YOGA IN BREAST CANCER SURVIVORS ARE WARRANTED. IMPLICATIONS FOR PRACTICE: NURSES MAY CONSIDER IY AS A POSSIBLE INTERVENTION STRATEGY TO HELP BREAST CANCER SURVIVORS IMPROVE THEIR QOL AND PSYCHOSOCIAL FUNCTIONING. 2010 19 557 58 COST-EFFECTIVENESS OF YOGA FOR CHRONIC LOW BACK PAIN IN VETERANS. BACKGROUND: YOGA INTERVENTIONS CAN IMPROVE FUNCTION AND REDUCE PAIN IN PERSONS WITH CHRONIC LOW BACK PAIN (CLBP). OBJECTIVE: USING DATA FROM A RECENT TRIAL OF YOGA FOR MILITARY VETERANS WITH CLBP, WE ANALYZED THE INCREMENTAL COST-EFFECTIVENESS OF YOGA COMPARED WITH USUAL CARE. METHODS: PARTICIPANTS (N=150) WERE RANDOMIZED TO EITHER 2X WEEKLY, 60-MINUTE YOGA SESSIONS FOR 12 WEEKS, OR TO DELAYED TREATMENT (DT). OUTCOMES WERE MEASURED AT 12 WEEKS, AND 6 MONTHS. QUALITY-ADJUSTED LIFE YEARS (QALYS) WERE MEASURED USING THE EQ-5D SCALE. A 30% IMPROVEMENT ON THE ROLAND-MORRIS DISABILITY QUESTIONNAIRE (PRIMARY OUTCOME) SERVED AS AN ADDITIONAL EFFECTIVENESS MEASURE. INTERVENTION COSTS INCLUDING PERSONNEL, MATERIALS, AND TRANSPORTATION WERE TRACKED DURING THE STUDY. HEALTH CARE COSTS WERE OBTAINED FROM PATIENT MEDICAL RECORDS. HEALTH CARE ORGANIZATION AND SOCIETAL PERSPECTIVES WERE EXAMINED WITH A 12-MONTH HORIZON. RESULTS: INCREMENTAL QALYS GAINED BY THE YOGA GROUP OVER 12 MONTHS WERE 0.043. INTERVENTION COSTS TO DELIVER YOGA WERE $307/PARTICIPANT. NEGLIGIBLE DIFFERENCES IN HEALTH CARE COSTS WERE FOUND BETWEEN GROUPS. FROM THE HEALTH CARE ORGANIZATION PERSPECTIVE, THE INCREMENTAL COST-EFFECTIVENESS RATIO TO PROVIDE YOGA WAS $4488/QALY. FROM THE SOCIETAL PERSPECTIVE, YOGA WAS "DOMINANT" PROVIDING BOTH HEALTH BENEFIT AND COST SAVINGS. PROBABILISTIC SENSITIVITY ANALYSIS INDICATES AN 89% CHANCE OF YOGA BEING COST-EFFECTIVE AT A WILLINGNESS-TO-PAY OF $50,000. A SCENARIO COMPARING THE COSTS OF YOGA AND PHYSICAL THERAPY SUGGEST THAT YOGA MAY PRODUCE SIMILAR RESULTS AT A MUCH LOWER COST. DISCUSSION/CONCLUSIONS: YOGA IS A COST-EFFECTIVE TREATMENT FOR REDUCING PAIN AND DISABILITY AMONG MILITARY VETERANS WITH CLBP. 2020 20 1107 40 EFFECTS OF YOGA, STRENGTH TRAINING AND ADVICE ON BACK PAIN: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: AMONG THE WORKING POPULATION, NON-SPECIFIC LOW-BACK PAIN AND NECK PAIN ARE ONE OF THE MOST COMMON REASONS FOR SICKNESS ABSENTEEISM. THE AIM WAS TO EVALUATE THE EFFECTS OF AN EARLY INTERVENTION OF YOGA - COMPARED WITH STRENGTH TRAINING OR EVIDENCE-BASED ADVICE - ON SICKNESS ABSENTEEISM, SICKNESS PRESENTEEISM, BACK AND NECK PAIN AND DISABILITY AMONG A WORKING POPULATION. METHODS: A RANDOMIZED CONTROLLED TRIAL WAS CONDUCTED ON 159 PARTICIPANTS WITH PREDOMINANTLY (90%) CHRONIC BACK AND NECK PAIN. AFTER SCREENING, THE PARTICIPANTS WERE RANDOMIZED TO KUNDALINI YOGA, STRENGTH TRAINING OR EVIDENCE-BASED ADVICE. PRIMARY OUTCOME WAS SICKNESS ABSENTEEISM. SECONDARY OUTCOMES WERE SICKNESS PRESENTEEISM, BACK AND NECK PAIN AND DISABILITY. SELF-REPORTED QUESTIONNAIRES AND SMS TEXT MESSAGES WERE COMPLETED AT BASELINE, 6 WEEKS, 6 AND 12 MONTHS. RESULTS: THE RESULTS DID NOT INDICATE THAT KUNDALINI YOGA AND STRENGTH TRAINING HAD ANY STATISTICALLY SIGNIFICANT EFFECTS ON THE PRIMARY OUTCOME COMPARED WITH EVIDENCE-BASED ADVICE. AN INTERACTION EFFECT WAS FOUND BETWEEN ADHERENCE TO RECOMMENDATIONS AND SICKNESS ABSENTEEISM, INDICATING LARGER SIGNIFICANT EFFECTS AMONG THE ADHERERS TO KUNDALINI YOGA VERSUS EVIDENCE-BASED ADVICE: RR = 0.47 (CI 0.30; 0.74, P = 0.001), STRENGTH TRAINING VERSUS EVIDENCE-BASED ADVICE: RR = 0.60 (CI 0.38; 0.96, P = 0.032). SOME SIGNIFICANT DIFFERENCES WERE ALSO FOUND FOR THE SECONDARY OUTCOMES TO THE ADVANTAGE OF KUNDALINI YOGA AND STRENGTH TRAINING. CONCLUSIONS: GUIDED EXERCISE IN THE FORMS OF KUNDALINI YOGA OR STRENGTH TRAINING DOES NOT REDUCE SICKNESS ABSENTEEISM MORE THAN EVIDENCE-BASED ADVICE ALONE. HOWEVER, SECONDARY ANALYSES REVEAL THAT AMONG THOSE WHO PURSUE KUNDALINI YOGA OR STRENGTH TRAINING AT LEAST TWO TIMES A WEEK, A SIGNIFICANTLY REDUCTION IN SICKNESS ABSENTEEISM WAS FOUND. METHODS TO INCREASE ADHERENCE TO TREATMENT RECOMMENDATIONS SHOULD BE FURTHER DEVELOPED AND APPLIED IN EXERCISE INTERVENTIONS. TRIAL REGISTRATION: CLINICALTRIALS.GOV NCT01653782, DATE OF REGISTRATION: JUNE, 28, 2012, RETROSPECTIVELY REGISTERED. 2017